IPP Bureau
Pfizer’s Covid-19 drug 90 % effective
By IPP Bureau - December 15, 2021
The data has been shared with the U.S.FDA as part of an ongoing rolling submission for Emergency Use Authorisation
CellCarta acquires Biogazelle to strengthen its genomic capabilities
By IPP Bureau - December 15, 2021
While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta's Center of Excellence for the development of complex genomic biomarker assays
Lo.Li Pharma International seeks partners for Deplesin therapy
By IPP Bureau - December 15, 2021
Deplesin is an add-on therapy to gold standard agents like lithium, valproic acid, and carbamazepine, supporting patients in ways that prescription medications often cannot
Biogen and TheraPanacea collaborate to advance digital health in neuroscience
By IPP Bureau - December 15, 2021
Collaboration aims to develop innovative machine learning and artificial intelligence solutions for personalized and earlier treatment in neurology
Immatics and Bristol Myers Squibb enter exclusive license for TCR Bispecific programme
By IPP Bureau - December 15, 2021
Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales
HealthPlix releases Prescription Summary Dashboard for doctors
By IPP Bureau - December 15, 2021
Doctors can now analyse their historical prescriptions within a few clicks enabling them to identify different cohorts of patients and the treatment given to them
Aragen Life Sciences acquires Intox
By IPP Bureau - December 15, 2021
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
Fullife Healthcare raises US $ 22 mn in Series C funding
By IPP Bureau - December 15, 2021
This round of funding will support Fast&Up and Chicnutrix to expand their domestic presence, enhance manufacturing capabilities and accelerate momentum globally
Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA
By IPP Bureau - December 15, 2021
During H1 FY2022, the revenues and operating profit margin (OPM) for ICRA sample set showed sharp improvement aided by volume uptick in Covid-19 and allied tests and also demand traction for non-Covid tests
Baxter acquires Hillrom for US $ 15 billion
By IPP Bureau - December 14, 2021
It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home
Moderna to set up mRNA vaccine manufacturing facility in Australia
By IPP Bureau - December 14, 2021
Up to 100 million mRNA vaccine doses could be produced in Australia each year
Novartis announces next-generation CAR-T platform, T Charge
By IPP Bureau - December 14, 2021
T-Charge, a next-generation platform that aims to revolutionize CAR-T cell therapy, will serve as the foundation for various investigational CAR-T therapies
Pfizer to acquire Arena Pharmaceuticals for US $ 6.7 bn
By IPP Bureau - December 14, 2021
The proposed acquisition offers a potentially new, differentiated best-in-class approach to address the unmet need for a broader number of patients with immuno-inflammatory diseases
Atik Cameras launches the TE-77 advanced scientific solution
By IPP Bureau - December 14, 2021
Atik Cameras invests in new CCD sensor technology to create an advanced scientific and industrial imaging solution, using the Teledyne e2v CCD77-00 sensor
Lupin’s Goa plant receives EIR from US FDA
By IPP Bureau - December 14, 2021
FDA changes inspection classification of the facility to Voluntary Action Indicated
